Iron supplement in cancer patients receiving erythropoietin.

Salvatore Siena, Paolo Pedrazzoli, Cinzia Tullio, Giulio Cerea

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4428; author reply 4428-9

PMID: 15514387

Full Text on Atypon View on PubMed

Abstract

DOI: 10.1200/JCO.2004.04.860

Link outs

Free resources

Medical:

https://medlineplus.gov/anemia.html

Subscription / membership required

Full Text Sources:

https://ascopubs.org/doi/10.1200/JCO.2004.04.860?u...
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Anemia, Antineoplastic Agents, Erythropoietin, Humans, Iron, Iron-Dextran Complex, Neoplasms, Randomized Controlled Trials as Topic, Recombinant Proteins

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.